Prognostic impact of organ involvement in aggressive adult T-cell leukemia/lymphoma: definition of risk organ and proposal of a prognostic index
Sign Up to like & getrecommendations! Published in 2025 at "Blood Cancer Journal"
DOI: 10.1038/s41408-025-01367-w
Abstract: To the Editor: Adult T-cell leukemia/lymphoma (ATL) is a lymphoma with a very poor prognosis, originating from the tumorigenesis of human T-cell leukemia virus (HTLV)-1-infected T lymphocytes [1, 2]. The acute, lymphoma, and chronic types… read more here.
Keywords: aggressive atl; stage; cell leukemia; lymphoma ... See more keywords
Upfront allo-HSCT after intensive chemotherapy for untreated aggressive ATL: JCOG0907, a single-arm, phase 3 trial.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.7001
Abstract: 7001 Background: Aggressive adult T-cell leukemia-lymphoma (ATL) (i.e., acute, lymphoma and unfavorable chronic types) has poor prognosis with around a 1-year median survival time (MST) with chemotherapy. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) provides a… read more here.
Keywords: aggressive atl; allo hsct; trial; chemotherapy ... See more keywords